Publications

2020

  1. Myller, S, Ipatti, P, Jääskeläinen, A, Haapasaari, KM, Jukkola, A, Karihtala, P et al.. Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses. Acta Oncol. 2020; :1-7. doi: 10.1080/0284186X.2020.1760350. PubMed PMID:32394761 .

Search PubMed

2019

  1. Jääskeläinen, A, Jukkola, A, Haapasaari, KM, Auvinen, P, Soini, Y, Karihtala, P et al.. Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer. Anticancer Res. 2019;39 (11):5879-5890. doi: 10.21873/anticanres.13792. PubMed PMID:31704812 .
  2. Tiainen, L, Korhonen, EA, Leppänen, VM, Luukkaala, T, Hämäläinen, M, Tanner, M et al.. High baseline Tie1 level predicts poor survival in metastatic breast cancer. BMC Cancer. 2019;19 (1):732. doi: 10.1186/s12885-019-5959-8. PubMed PMID:31340773 PubMed Central PMC6657075.
  3. Jääskeläinen, A, Jukkola, A, Risteli, J, Haapasaari, KM, Karihtala, P. Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer. Tumour Biol. 2019;41 (5):1010428319847081. doi: 10.1177/1010428319847081. PubMed PMID:31122159 .
  4. Tiainen, L, Hämäläinen, M, Luukkaala, T, Tanner, M, Lahdenperä, O, Vihinen, P et al.. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clin. Breast Cancer. 2019;19 (4):e522-e533. doi: 10.1016/j.clbc.2019.03.006. PubMed PMID:31029558 .
  5. Hosio, M, Urpilainen, E, Marttila, M, Hautakoski, A, Arffman, M, Sund, R et al.. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast Cancer Res. Treat. 2019;175 (3):741-748. doi: 10.1007/s10549-019-05185-0. PubMed PMID:30895533 PubMed Central PMC6534663.

Search PubMed